Thus the high risk of MCC in the segmental colectomy cohort is largely due to patients with MLH1 and MSH2 mutations, and therefore germline specific information must be taken in to account when counselling patients about the risks of surgery [13, 25]. Here, MLH1 is linked to Merkel cell skin cancer.